StockData
CapsoVision, Inc logo

CapsoVision, Inc (CV) stock

CVNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30733% above fair value
$6.82+0.17 (+2.56%)

Close on Nov 18, 2026Market cap $341.32MP/E –Yield –

CapsoVision net income

Net income is the profit left for shareholders after every expense, interest and tax.

CapsoVision's net income for the twelve months ending Jun 30, 2026 was -$29.83M. For fiscal 2025 it was -$25.32M.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$25.32M–
FY2024Dec 31, 2024-$19.90M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$7.48M–
Q1 FY2026Mar 31, 2026-$7.03M–
Q4 FY2025Dec 31, 2025-$7.39M–
Q3 FY2025Sep 30, 2025-$7.92M–
Q2 FY2025Jun 30, 2025-$4.63M–
Q1 FY2025Mar 31, 2025-$5.38M–
Q4 FY2024Dec 31, 2024-$4.64M–
Q3 FY2024Sep 30, 2024-$5.79M–
Q2 FY2024Jun 30, 2024-$5.27M–
Q1 FY2024Mar 31, 2024-$4.20M–

More CapsoVision figures

See a number that looks wrong?